Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Rodvold

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|January 1, 1988
Therapeutic considerations for infections caused by Staphylococcus epidermidisK A Rodvold
Clinical Pharmacokinetics|December 10, 1999
Clinical pharmacokinetics of clarithromycinK A Rodvold
Pharmacotherapy|November 1, 1993
Pharmacotherapy of infectious complications in patients with acquired immunodeficiency syndromeK A Rodvold
Pharmacotherapy|November 21, 2001
Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedsideK A Rodvold
Pharmacotherapy|October 20, 2001
Pharmacokinetics and pharmacodynamics of fluoroquinolonesK A Rodvold, M Neuhauser
Annals of Emergency Medicine|February 1, 1988
Evaluation of theophylline overdoses and toxicitiesF P Paloucek, K A Rodvold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1993
New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safetyK A Rodvold, S C Piscitelli
Journal of Clinical Pharmacology|May 1, 1987
Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycinK A Rodvold, R A Blum
The Annals of Pharmacotherapy|April 1, 1992
Fluoroquinolone treatment of Enterococcus infectionD N Fish, K A Rodvold
Drug Safety|June 1, 1995
How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?C A Gentry, K A Rodvold
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|January 1, 1988
Therapeutic considerations for infections caused by Staphylococcus epidermidisK A Rodvold
Clinical Pharmacokinetics|December 10, 1999
Clinical pharmacokinetics of clarithromycinK A Rodvold
Pharmacotherapy|November 1, 1993
Pharmacotherapy of infectious complications in patients with acquired immunodeficiency syndromeK A Rodvold
Pharmacotherapy|November 21, 2001
Pharmacodynamics of antiinfective therapy: taking what we know to the patient's bedsideK A Rodvold
Pharmacotherapy|October 20, 2001
Pharmacokinetics and pharmacodynamics of fluoroquinolonesK A Rodvold, M Neuhauser
Annals of Emergency Medicine|February 1, 1988
Evaluation of theophylline overdoses and toxicitiesF P Paloucek, K A Rodvold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 1, 1993
New oral macrolide and fluoroquinolone antibiotics: an overview of pharmacokinetics, interactions, and safetyK A Rodvold, S C Piscitelli
Journal of Clinical Pharmacology|May 1, 1987
Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycinK A Rodvold, R A Blum
The Annals of Pharmacotherapy|April 1, 1992
Fluoroquinolone treatment of Enterococcus infectionD N Fish, K A Rodvold
Drug Safety|June 1, 1995
How important is therapeutic drug monitoring in the prediction and avoidance of adverse reactions?C A Gentry, K A Rodvold
Pageof 9